학술논문
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
Document Type
Article
Author
Source
In Annals of Oncology October 2016 27(10):1947-1947
Subject
Language
ISSN
0923-7534